+ All Categories
Home > Health & Medicine > Anesthesia Management in IHD Patients

Anesthesia Management in IHD Patients

Date post: 14-Apr-2017
Category:
Upload: reza-aminnejad
View: 280 times
Download: 7 times
Share this document with a friend
19
Management Of Anesthesia In Ischemic Hear Disease Patients (brief practical review) Reza Aminnejad; M.D. Anesthesiologist.
Transcript
Page 1: Anesthesia Management in IHD Patients

Management Of Anesthesia In Ischemic Hear Disease

Patients(brief practical review)

Reza Aminnejad; M.D.Anesthesiologist.

Page 2: Anesthesia Management in IHD Patients
Page 3: Anesthesia Management in IHD Patients

In The Name of God

Page 4: Anesthesia Management in IHD Patients

Ischemic Heart Disease

Page 5: Anesthesia Management in IHD Patients

Management of anesthesia in patients with known or suspected IHD undergoing

non cardiac surgery

Page 6: Anesthesia Management in IHD Patients

Intraoperative Management (Basic Challenges)

Prevent myocardial ischemia by optimizing myocardial oxygen supply and reducing myocardial oxygen demand

Monitor for ischemia and treat ischemia if it develops.

Page 7: Anesthesia Management in IHD Patients

Intraoperative Events That Influence the Balance Between Myocardial Oxygen Delivery and Myocardial Oxygen Requirements Decreased O2 Delivery (Decreased

coronary blood flow, Tachycardia, Diastolic hypotension, Hypocapnia (coronary artery vasoconstriction), Coronary artery spasm, Decreased oxygen content, Anemia, Arterial hypoxemia, Shift of the oxyhemoglobin dissociation curve to the left)

Increased O2 Requirements (Sympathetic nervous system stimulation, Tachycardia, Hypertension, Increased myocardial contractility, Increased afterload, Increased preload)

Page 8: Anesthesia Management in IHD Patients

Maintenance of the balance between myocardial oxygen supply and demand is more important than the specific anesthetic technique or drugs selected to produce anesthesia and muscle relaxation.

Page 9: Anesthesia Management in IHD Patients

A common recommendation is to keep the heart rate and blood pressure within 20% of the normal awake value.

Page 10: Anesthesia Management in IHD Patients

Induction of Anesthesia Intravenous induction drug is preferred. Short-duration direct laryngoscopy

(≤15 seconds) is considered. Laryngotracheal lidocaine, intravenous

lidocaine, esmolol, and fentanyl have all been shown to be useful for blunting the increase in heart rate evoked by tracheal intubation.

Page 11: Anesthesia Management in IHD Patients

Maintenance of Anesthesia In patients with normal LV function volatile

anesthetic with or without N2O or N2O– opioid technique with the addition of a volatile anesthetic to treat any undesirable increases in BP that accompany painful surgical stimulation is recommended.

In patients with severely impaired LV function opioids may be selected. A benzodiazepine may be needed for amnesia but the addition of N2O or a volatile anesthetic may be associated with myocardial depression.

It seems prudent to maintain intraoperative heart rate at less than 80 bpm.

Page 12: Anesthesia Management in IHD Patients

Choice of Muscle Relaxant Vecuronium, rocuronium &

cisatracurium have minimal or no effect on HR & SBP.

For reversal of neuromuscular blockade with an anticholinesterase / anticholinergic drug combination, glycopyrrolate, which has much less chronotropic effect, is better than Atropine.

Page 13: Anesthesia Management in IHD Patients

Monitoring ECG PCWP TEE

Page 14: Anesthesia Management in IHD Patients

Relationship of Electrocardiogram Leads to Areas of Myocardial Ischemia Leads II, III & aVF→ RCA→ RA, RV,

SA node, Inferior aspect of LV, AV node

Leads I & aVL→ CCA→ Lateral aspect of LV

Leads V3–V5→ LAD→ Anterolateral aspect of LV

Page 15: Anesthesia Management in IHD Patients

Pulmonary Artery Catheter Intraoperative myocardial ischemia can manifest as

an acute increase in pulmonary artery occlusion pressure due to changes in left ventricular compliance and systolic performance.

A pulmonary artery catheter is not a sensitive monitor for detecting small ischemic insults but it can be more useful as a guide in the treatment of myocardial dysfunction.

Use of a pulmonary artery catheter has not been shown to be associated with improved outcomes.

CVP and pulmonary artery occlusion pressure correlate in patients with ischemic heart disease when the ejection fraction is greater than 50% .

Page 16: Anesthesia Management in IHD Patients

TEE (Trans Esophageal Echocardiography)

Regional wall motion abnormalities occur before ECG changes occur.

The limitations of TEE include its cost, the need for extensive training in interpretation, and the fact that it cannot be inserted until after induction of anesthesia.

Page 17: Anesthesia Management in IHD Patients

Intraoperative Management of Myocardial Ischemia

Treatment of myocardial ischemia should be instituted when there are 1-mm ST-segment changes on the ECG.

Prompt, aggressive pharmacologic treatment of changes in heart rate and/or blood pressure is indicated.

Consider esmolol for persistent increas in HR & nitroglycerin for normal or modestly elevated BP.

Hypotension is treated with sympathomimetic drugs to restore coronary perfusion pressure.

In an unstable hemodynamic situation, circulatory support with inotropes or an intra-aortic balloon pump may be necessary.

Page 18: Anesthesia Management in IHD Patients

Postoperative Management Prevent intraoperative hypothermia, pain,

hypoxemia, hypercarbia, sepsis, and hemorrhage.

Continue β-blockers throughout the perioperative period.

Maintain intravascular volume and an adequate hemoglobin concentration.

patients with IHD can become ischemic during emergence from anesthesia and/or weaning with an increased heart rate and blood pressure.

Page 19: Anesthesia Management in IHD Patients

Recommended